Patent Assignment
Reel/Frame 019988/0963
Assignment of Assignor's Interest
Recorded: 2007-10-19
Pages: 8
Assignor
PHOENIX PHARMACOLOGICS, INC.
Executed: 2007-10-04
Assignee
POLARIS GROUP
9F, NO. 289, CHUNG-XIAO EAST ROAD, SECTION 4, TAIPEI, TAIWAN, 106, CHINA
Covered Properties
(8)
Novel Mutated Form of Arginine Deiminase
Patent:
6,635,462 →
Application:
09/564,559 →
Modified Arginine Deiminase
Patent:
6,737,259 →
Application:
09/723,546 →
Yeast Expression Systems, Methods of Producing Polypeptides in Yeast, and Compositions Relating to Same
Peg-Modified Uricase
Methods for Inhibiting Viral Replication in Vivo
Method of Treatment with Modified Arginine Deiminase
Modified Tumor Necrosis Factor
Methods For Inhibiting Viral Replication In Vivo
Application:
11/689,166 →
Publication:
US 2007/0172469
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 6, 2000
From: ENSOR, CHARLES MARK; HOLTSBERG, FREDERICK WAYNE; CLARK, MIKE A.
To: PHOENIX PHARMACOLOGICS, INC.
Reel/Frame 010946/0348 →
Assignment of Assignor's Interest
Feb 28, 2001
From: CLARK, MIKE A.
To: PHOENIX PHARMACOLOGICS, INC.
Reel/Frame 011556/0061 →
Assignment of Assignor's Interest
Sep 28, 2001
From: CLARK, MIKE A.
To: PHOENIX PHARMACOLOGIES, INC.
Reel/Frame 012209/0229 →
Assignment of Assignor's Interest
Jan 3, 2002
From: ENSOR, CHARLES MARK; CLARK, MIKE A.; HOLTSBERG, FREDERICK WAYNE
To: PHOENIX PHARMACOLOGICS, INC.
Reel/Frame 012425/0444 →
Assignment of Assignor's Interest
Mar 10, 2004
From: CLARK, MIKE
To: PHOENIX PHARMACOLOGICS, INC.
Reel/Frame 015043/0500 →
Assignment of Assignor's Interest
Oct 14, 2010
From: POLARIS GROUP
To: ENZYMERX, LLC
Reel/Frame 025137/0144 →
Assignment of Assignor's Interest
Sep 6, 2011
From: ENZYMERX, LLC
To: 3SBIO, LLC IP ASSET SERIES
Reel/Frame 026856/0253 →
Assignment of Assignor's Interest
Jul 9, 2012
From: 3SBIO LLC IP ASSET SERIES
To: SHENYANG SUNSHINE PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 028510/0048 →